×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DBVT – dbv technologies s.a. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DBVT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/15
04:35 am
dbvt
DBV Technologies Details VIASKIN Peanut BLA Timeline, Launch Plan at Citizens Life Sciences Conference [Yahoo! Finance]
Low
Report
DBV Technologies Details VIASKIN Peanut BLA Timeline, Launch Plan at Citizens Life Sciences Conference [Yahoo! Finance]
3/7
08:33 pm
dbvt
Is It Too Late To Consider DBV Technologies (ENXTPA:DBV) After Peanut Allergy Patch Headlines? [Yahoo! Finance]
Medium
Report
Is It Too Late To Consider DBV Technologies (ENXTPA:DBV) After Peanut Allergy Patch Headlines? [Yahoo! Finance]
3/4
04:58 pm
dbvt
DBV Technologies to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Low
Report
DBV Technologies to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
3/4
04:30 pm
dbvt
DBV Technologies to Participate in Upcoming March Investor Conferences
Low
Report
DBV Technologies to Participate in Upcoming March Investor Conferences
3/3
04:30 pm
dbvt
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026
Medium
Report
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026
3/2
07:35 am
dbvt
Assessing DBV Technologies (ENXTPA:DBV) Valuation After Mixed Recent Share Performance [Yahoo! Finance]
Medium
Report
Assessing DBV Technologies (ENXTPA:DBV) Valuation After Mixed Recent Share Performance [Yahoo! Finance]
2/28
02:54 pm
dbvt
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting [Yahoo! Finance]
High
Report
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting [Yahoo! Finance]
2/28
02:25 pm
dbvt
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
High
Report
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/2
07:54 am
dbvt
Form 8-K DBV Technologies S.A. For: Feb 28
Medium
Report
Form 8-K DBV Technologies S.A. For: Feb 28
2/17
06:08 pm
dbvt
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Venrock Healthcare Capital Partners II, L.P.
Low
Report
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Venrock Healthcare Capital Partners II, L.P.
2/17
04:38 pm
dbvt
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: CITADEL ADVISORS LLC
Low
Report
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: CITADEL ADVISORS LLC
2/17
04:12 pm
dbvt
Form SCHEDULE 13G DBV Technologies S.A. Filed by: MPM BioImpact LLC
Low
Report
Form SCHEDULE 13G DBV Technologies S.A. Filed by: MPM BioImpact LLC
2/13
06:12 pm
dbvt
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Vivo Opportunity Fund Holdings, L.P.
Low
Report
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Vivo Opportunity Fund Holdings, L.P.
2/13
11:25 am
dbvt
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Invus Global Management, LLC
Medium
Report
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Invus Global Management, LLC
2/3
02:00 pm
dbvt
Form SCHEDULE 13G DBV Technologies S.A. Filed by: Artisan Partners Limited Partnership
Low
Report
Form SCHEDULE 13G DBV Technologies S.A. Filed by: Artisan Partners Limited Partnership
2/2
04:30 pm
dbvt
Form 4 DBV Technologies S.A. For: Jan 29 Filed by: Mohideen Pharis
Medium
Report
Form 4 DBV Technologies S.A. For: Jan 29 Filed by: Mohideen Pharis
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Bryan, Garnier & Co from a "buy" rating to a "neutral" rating.
27.9%
3/17 Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 29, 2020 and March 4, 2020 25.8%
1/8 DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy 14.8%
4/21 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 14.1%
4/14 Form 6-K DBV Technologies S.A. For: Apr 13 13.6%
4/7 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.25 price target on the stock. 10.6%
7/3 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 10.2%
8/7 DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy 9.5%
2/26 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 7.7%
4/15 Monthly information regarding the total number of voting rights and total number of shares of the Company 5.8%
3/17 Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 29, 2020 and March 4, 2020 25.8%
1/8 DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy 14.8%
4/21 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 14.1%
4/14 Form 6-K DBV Technologies S.A. For: Apr 13 13.6%
4/7 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.25 price target on the stock. 10.6%
7/3 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 10.2%
8/7 DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy 9.5%
2/26 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 7.7%
4/15 Monthly information regarding the total number of voting rights and total number of shares of the Company 5.8%
TOP News Decliners
3/10
DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.25 price target on the stock.
-14.2%
1/29 Form 6-K DBV Technologies S.A. For: Jan 29 -13.2%
3/12 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -11.7%
3/20 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Kepler Capital Markets from a "buy" rating to a "hold" rating. -11.6%
12/20 DBV TECHNOLOGIE/S (NASDAQ: DBVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock. -8.7%
2/4 Form 6-K DBV Technologies S.A. For: Feb 04 -8.6%
3/5 DBV TECHNOLOGIE/S (NASDAQ: DBVT) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $18.00 price target on the stock. -8.5%
1/9 Form 6-K DBV Technologies S.A. For: Jan 08 -8.4%
10/9 DBV Technologies Announces Pricing of $125 million (€114 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares -8.2%
4/14 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.75 price target on the stock. -8.2%
1/29 Form 6-K DBV Technologies S.A. For: Jan 29 -13.2%
3/12 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -11.7%
3/20 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Kepler Capital Markets from a "buy" rating to a "hold" rating. -11.6%
12/20 DBV TECHNOLOGIE/S (NASDAQ: DBVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock. -8.7%
2/4 Form 6-K DBV Technologies S.A. For: Feb 04 -8.6%
3/5 DBV TECHNOLOGIE/S (NASDAQ: DBVT) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $18.00 price target on the stock. -8.5%
1/9 Form 6-K DBV Technologies S.A. For: Jan 08 -8.4%
10/9 DBV Technologies Announces Pricing of $125 million (€114 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares -8.2%
4/14 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.75 price target on the stock. -8.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: